Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial
Articolo
Data di Pubblicazione:
2019
Abstract:
The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Monotherapy; Phase I/II trial; Prostate cancer; SBRT; Toxicity
Elenco autori:
Zilli, T.; Franzese, C.; Bottero, M.; Giaj-Levra, N.; Forster, R.; Zwahlen, D.; Koutsouvelis, N.; Bertaut, A.; Blanc, J.; Roberto D'agostino, G.; Alongi, F.; Guckenberger, M.; Scorsetti, M.; Miralbell, R.
Link alla scheda completa:
Pubblicato in: